Neidler, S.; Kruspig, B.; Hewit, K.; Monteverde, T.; Gyuraszova, K.; Braun, A.; Clark, W.; James, D.; Hedley, A.; Nieswandt, B.;
et al. Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma. Cancers 2019, 11, 600.
https://doi.org/10.3390/cancers11050600
AMA Style
Neidler S, Kruspig B, Hewit K, Monteverde T, Gyuraszova K, Braun A, Clark W, James D, Hedley A, Nieswandt B,
et al. Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma. Cancers. 2019; 11(5):600.
https://doi.org/10.3390/cancers11050600
Chicago/Turabian Style
Neidler, Sarah, Björn Kruspig, Kay Hewit, Tiziana Monteverde, Katarina Gyuraszova, Attila Braun, William Clark, Daniel James, Ann Hedley, Bernhard Nieswandt,
and et al. 2019. "Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma" Cancers 11, no. 5: 600.
https://doi.org/10.3390/cancers11050600
APA Style
Neidler, S., Kruspig, B., Hewit, K., Monteverde, T., Gyuraszova, K., Braun, A., Clark, W., James, D., Hedley, A., Nieswandt, B., Shanks, E., Dick, C., & Murphy, D. J.
(2019). Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma. Cancers, 11(5), 600.
https://doi.org/10.3390/cancers11050600